02:03 PM EST, 01/10/2025 (MT Newswires) -- NeuroOne Medical Technologies ( NMTC ) shares rose more than 9% in recent trading Friday after it said it expects fiscal Q1 revenue of $6.2 million, up from $1 million a year earlier.

The company said the quarter ended Dec. 31, 2024, includes a one-time $3 million payment of collaboration revenue from the expanded distribution deal with Zimmer Biomet Holdings ( ZBH ) for commercialization of NeuroOne's OneRF Ablation System.

Price: 1.17, Change: +0.10, Percent Change: +9.35